Qixia Xu

1.9k total citations · 1 hit paper
27 papers, 916 citations indexed

About

Qixia Xu is a scholar working on Physiology, Molecular Biology and Immunology. According to data from OpenAlex, Qixia Xu has authored 27 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Qixia Xu's work include Telomeres, Telomerase, and Senescence (9 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Qixia Xu is often cited by papers focused on Telomeres, Telomerase, and Senescence (9 papers), Venous Thromboembolism Diagnosis and Management (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Qixia Xu collaborates with scholars based in China, United States and United Kingdom. Qixia Xu's co-authors include Yu Sun, Judith Campisi, Qiang Fu, Da Fu, Zi Li, Hanxin Liu, Min Qian, Han Liu, Boyi Zhang and James L. Kirkland and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Qixia Xu

25 papers receiving 912 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice

2021 217 citations Qixia Xu, Qiang Fu et al. Nature Metabolism profile →

Peers

Countries citing papers authored by Qixia Xu

Since Specialization

Citations

This map shows the geographic impact of Qixia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qixia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qixia Xu more than expected).

Fields of papers citing papers by Qixia Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qixia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qixia Xu. The network helps show where Qixia Xu may publish in the future.

Co-authorship network of co-authors of Qixia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qixia Xu. A scholar is included among the top collaborators of Qixia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qixia Xu. Qixia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting Senescence with Apigenin Improves Chemotherapeutic Efficacy and Ameliorates Age‐Related Conditions in Mice 2025 ·Advanced Science ·Hongwei Zhang, Qixia Xu, Zhirui Jiang, Rong Sun, Qun Wang, Sanhong Liu, Xin Luan, (unknown), James L. Kirkland, Weidong Zhang, Yu Sun	8
2	KDM4 Orchestrates Epigenomic Remodeling of Senescent Cells and Potentiates the Senescence‐Associated Secretory Phenotype 2025 ·Aging Cell ·Boyi Zhang, Qilai Long, Shanshan Wu, Qixia Xu, Shuling Song, Han Liu, Min Qian, Xiaohui Ren, Hanxin Liu, Jing Jiang, Jianming Guo, Xiaoling Zhang, Xing Chang, Qiang Fu, Eric W.‐F. Lam, (unknown), James L. Kirkland, Yu Sun	0
3	Clinical characteristics and mortality of mucormycosis in hematological malignancies: a retrospective study in Eastern China 2024 ·Annals of Clinical Microbiology and Antimicrobials ·Tao Suo, Mengmeng Xu, Qixia Xu	2
4	Closure of a secondary tracheoesophageal fistula in severe pneumonia using an Amplatzer Duct Occluder II during invasive mechanical ventilation: A case report 2024 ·SHILAP Revista de lepidopterología ·(unknown), Dongsheng Wang, Jialiang Wang, Qixia Xu, (unknown), (unknown)	1
5	Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy 2023 ·Aging Cell ·Hanxin Liu, Qixia Xu, (unknown), Zi Li, Rong Sun, Zhirui Jiang, Xuefeng Dou, Qiang Fu, Judith Campisi, Yu Sun	55
6	PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy 2023 ·Nature Metabolism ·Xuefeng Dou, Qiang Fu, Qilai Long, Shuning Liu, Yejun Zou, Da Fu, Qixia Xu, Zhirui Jiang, Xiaohui Ren, Guilong Zhang, Xiaoling Wei, Qingfeng Li, Judith Campisi, Yuzheng Zhao, Yu Sun	88
7	Acute Respiratory Distress Syndrome Caused by Occupational Exposure to Waterproofing Spray: A Case Report and Literature Review 2022 ·Frontiers in Public Health ·(unknown), Chun-Mei Feng, (unknown), Xiaowen Hu, Qixia Xu, (unknown), (unknown), (unknown), Wang Xie, Yuan Fang, (unknown), Junqiang Zhang	4
8	Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance 2022 ·Oncogene ·(unknown), Qilai Long, Qiang Fu, Qixia Xu, Da Fu, Yan Li, Libin Gao, Jianming Guo, Xiaoling Zhang, Eric W.‐F. Lam, Judith Campisi, Yu Sun	20
9	Metagenomic Next-Generation Sequencing Is Highly Efficient in Diagnosing Pneumocystis Jirovecii Pneumonia in the Immunocompromised Patients 2022 ·Frontiers in Microbiology ·Dongsheng Wang, (unknown), Xiaowen Hu, Qixia Xu, (unknown), (unknown), Wang Xie	21
10	The flavonoid procyanidin C1 has senotherapeutic activity and increases lifespan in mice breakdown → 2021 ·Nature Metabolism ·Qixia Xu, Qiang Fu, Zi Li, Hanxin Liu, Ying Wang, Xu Lin, Ruikun He, Xuguang Zhang, Zhenyu Ju, Judith Campisi, James L. Kirkland, Yu Sun	217
11	Mitochondrial dysfunction: A potential target for Alzheimer’s disease intervention and treatment 2021 ·Drug Discovery Today ·(unknown), (unknown), Qixia Xu, (unknown), Qiang Fu	18
12	Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD‐L1)‐mediated immunosuppression 2019 ·Aging Cell ·Qixia Xu, Qilai Long, Dexiang Zhu, Da Fu, Boyi Zhang, Han Liu, Min Qian, Jianming Guo, Jianmin Xu, Liu Cao, Y. Eugene Chin, Jean‐Philippe Coppé, Eric W.‐F. Lam, Judith Campisi, Yu Sun	90
13	Alterations to the Lung Microbiome in Idiopathic Pulmonary Fibrosis Patients 2019 ·Frontiers in Cellular and Infection Microbiology ·Xunliang Tong, Fei Su, Xiaomao Xu, Hongtao Xu, Ting Yang, Qixia Xu, Huaping Dai, Kewu Huang, Lihui Zou, Wenna Zhang, Surui Pei, Fei Xiao, Yanming Li, Chen Wang	28
14	Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance 2018 ·Nature Communications ·Fei Chen, Qilai Long, Da Fu, Dexiang Zhu, Yanhui Ma, Han Liu, Boyi Zhang, Qixia Xu, Bingjie Liu-Lastres, Yan Li, Shanshan Wu, Yang Chen, Min Qian, Jianmin Xu, Suling Liu, Liu Cao, Y. Eugene Chin, Eric W.‐F. Lam, Jean‐Philippe Coppé, Yu Sun	85
15	The senescence-associated secretory phenotype is potentiated by feedforward regulatory mechanisms involving Zscan4 and TAK1 2018 ·Nature Communications ·Boyi Zhang, Da Fu, Qixia Xu, Xianling Cong, Chunyan Wu, Xiaoming Zhong, Yu‐Shui Ma, Zhongwei Lv, Fei Chen, Han Liu, Min Qian, Y. Eugene Chin, Eric W.‐F. Lam, Paul J. Chiao, Yu Sun	110
16	Revisiting ovarian cancer microenvironment: a friend or a foe? 2017 ·Protein & Cell ·Boyi Zhang, Fei Chen, Qixia Xu, Han Liu, (unknown), Libin Gao, Xiaochen Sun, Yiwen Li, Yan Li, Min Qian, Yu Sun	40
17	TPS46, a Rice Terpene Synthase Conferring Natural Resistance to Bird Cherry-Oat Aphid, Rhopalosiphum padi (Linnaeus) 2017 ·Frontiers in Plant Science ·Yang Sun, Xinzheng Huang, Yuese Ning, (unknown), Toby J. A. Bruce, Fangjun Qi, Qixia Xu, Kongming Wu, Yongjun Zhang, Yuyuan Guo	32
18	Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension 2017 ·Chinese Medical Journal ·Qixia Xu, Yuanhua Yang, Jie Geng, Zhenguo Zhai, Juanni Gong, Jifeng Li, Xiao Tang, Chen Wang	9
19	Hypertension associated with venous thromboembolism in patients with newly diagnosed lung cancer 2016 ·Scientific Reports ·Yuhui Zhang, Yuanhua Yang, Wenhui Chen, Lirong Liang, Zhenguo Zhai, Lijuan Guo, Chen Wang, (unknown), (unknown), Qixia Xu, (unknown), Xinhong Zhang	21
20	Amphiregulin in Cancer: New Insights for Translational Medicine 2016 ·Trends in cancer ·Qixia Xu, Paul J. Chiao, Yu Sun	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact